A Biotype Enhancing Strategy For The Patient Undergoing Accelerated Orthodontics
Class I Malocclusion, Other Periodontal Diseases, Thin Gingival Biotype
About this trial
This is an interventional treatment trial for Class I Malocclusion focused on measuring orthodontics, periodontics, piezosurgery, accelerated orthodontics, Surgically Accelerated Orthodontic Treatment
Eligibility Criteria
Inclusion Criteria:
- Angle's class I malocclusion
- Little's grade II or III dental crowding
- Periodontally stable patients
- Patients with no more than 2 mm of keratinized gingiva in at least two sites of the antero-inferior region
Exclusion Criteria:
Patient with presence of marginal tissue recessions on inferior incisors
- Patients with a metabolic or neoplastic alteration
- History of orthopedic surgery in the last 6 months
- History of fractures in the last 6 months
- History of bisphosphonates use
- Patient with systemic compromise
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Active Comparator
Experimental
Experimental
Experimental
Conventional orthodontic treatment
Orthodontics with decortication
Orthodontics decortication and Mucograft
Orthodontics and Mucograft®
Patients that will receive conventional orthodontics
Patients that will receive orthodontic treatment with selective alveolar decortication
Orthodontic treatment, selective alveolar decortication and Mucograft® on the mandibular anterior segment
Patients that will receive orthodontic treatment and Mucograft® on the mandibular anterior segment